Microcyto微元合成 logo

Microcyto微元合成

微元合成(Microcyto)是一家以合成生物技术为基础的生物制造公司,至今 已完成多家明星投资机构参与的大额融资,已与多家国企和外企建立了广泛的交流与合作。公司业务聚焦于活性原料药、高附加值天然产物和大宗平台化合物等品类。

7 employees · est. 2021 · China

VS
OpenSpecimen (Biobanking LIMS) logo

OpenSpecimen (Biobanking LIMS)

Highly Configurable Biobanking (Biospecimen) LIMS Platform used in 90+ biobanks across 20+ countries.

16 employees · est. 2009 · Pune, India

OpenSpecimen (Biobanking LIMS) is the older company (2021 vs 2009); OpenSpecimen (Biobanking LIMS) is the larger of the two.

Side-by-Side Comparison

Microcyto微元合成 OpenSpecimen (Biobanking LIMS)
Founded
2021 2009 older
Headquarters
China Pune, India
Employees
7 16 larger
Industry
Biotechnology, Food and Beverage, Manufacturing Information Technology
Funding Stage
Seed Not tracked yet
Total Funding
$100.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Innovation in human nutrition and health through novel food ingredients, Bio-based animal nutrition solutions, Advanced pharmaceutical raw materials, Natural personal care ingredients, Agri-biologicals for enhanced crop production, Development of biological base materials Not tracked yet
Target Customers
Food & Beverage Companies, Agricultural and Aquaculture Industries, Pharmaceutical Manufacturers, Personal Care Product Companies, Environmental and Sustainability Organizations Not tracked yet
Taxonomy
Synthetic Biology, Biomanufacturing, Biotech Industry, Investment Funding, Collaborations, Active Pharmaceutical Ingredients, High Value Natural Products, Platform Compounds, China Science Academy, Tsinghua University, Sichuan University, Drug Development, Industrial Biotechnology, Multi-sector Applications Biobanking, Biorepository, Biospecimens, Biosamples, Samples, Specimens, LIMS Platform, Configurable, Academic Research, Oxford University, Johns Hopkins, Emory, University Of Pittsburgh, University Of Pennsylvania
Website
microcyto.cn openspecimen.org
Microcyto微元合成 logo

About Microcyto微元合成

Microcyto微元合成, founded in 2021 and headquartered in China, is a biotech powerhouse focusing on synthetic biology for biomanufacturing. The company's niche lies in developing active pharmaceutical ingredients, high-value natural products, and bulk chemicals. It is effectively tapping into a range...

OpenSpecimen (Biobanking LIMS) logo

About OpenSpecimen (Biobanking LIMS)

OpenSpecimen is a highly configurable Biobanking LIMS platform used in 90+ biobanks across 20+ countries. Established in 2009 and headquartered in India, it caters to the Information Technology industry. The platform is widely utilized by renowned academic research centers such as Oxford Univ, Johns...

We will tell you when either one moves

BounceWatch watches Microcyto微元合成 and OpenSpecimen (Biobanking LIMS) for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Microcyto微元合成 and OpenSpecimen (Biobanki... — by email.

Frequently Asked Questions

Microcyto微元合成 — 微元合成(Microcyto)是一家以合成生物技术为基础的生物制造公司,至今 已完成多家明星投资机构参与的大额融资,已与多家国企和外企建立了广泛的交流与合作。公司业务聚焦于活性原料药、高附加值天然产物和大宗平台化合物等品类。. OpenSpecimen (Biobanking LIMS) — Highly Configurable Biobanking (Biospecimen) LIMS Platform used in 90+ biobanks across 20+ countries.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Microcyto微元合成 has raised $100.00M while OpenSpecimen (Biobanking LIMS) has raised undisclosed funding.
Microcyto微元合成 and OpenSpecimen (Biobanking LIMS) operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Microcyto微元合成 with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Microcyto微元合成 on 11 Sep 2024, and OpenSpecimen (Biobanking LIMS) on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy